Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Lifestyle Natural Medicines

Moloney Securities Asset Management LLC Sells 50,000 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Moloney Securities Asset Management LLC lessened its stake in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 58.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned

By: ETF Daily News

Nov 18 2024
53
347 Views

Moloney Securities Asset Management LLC Sells 50,000 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Moloney Securities Asset Management LLC lessened its stake in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 58.8% in the 3rd quarter, according to the company in its most recent 13F fi… [+4398 chars]

Related

Moloney Securities Asset Management LLC Sells 50,000 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AMMO, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Agenus, and New Fortress and Encourages Investors to Contact the Firm

Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose

6 Expert-Approved Vitamins and Minerals Essential for Aging Well

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Major Shareholder Versant Venture Capital Vi, L. Sells 89,990 Shares

Exchange Traded Concepts LLC Has $158,000 Stock Position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE)

NKGen Biotech (NYSE:NKGN) versus Relay Therapeutics (NASDAQ:RLAY) Head-To-Head Contrast

Most Important Things You Need To Do Right Now To Be Prepared For a Natural or Man-Made Disaster

Digital pharma platform

Zombie Caterpillar Fungus Could Be Used to Save Human Lives

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AMMO, Metagenomi, Paragon 28, and New Fortress and Encourages Investors to Contact the Firm